PAPA (Papa Medical) Notes Receivable: $0.00 Mil (As of Mar. 2025)


What is Papa Medical Notes Receivable?

Papa Medical PAPA Notes Receivable is $0.00 Mil as of Mar. 2025.

Papa Medical's Notes Receivable for the quarter that ended in Mar. 2025 was $0.00 Mil.

Papa Medical Notes Receivable Historical Data

* Premium members only.

The historical data trend for Papa Medical's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical Notes Receivable Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
Notes Receivable
0.00 0.00 0.00

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Papa Medical Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Papa Medical (PAPA) has a Notes Receivable of $0.00 Mil as of Mar. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Papa Medical and its competitors.
Is Papa Medical's Notes Receivable too high?
Papa Medical's current Notes Receivable is $0.00 Mil.
How does Papa Medical's Notes Receivable compare to ?
Papa Medical's Notes Receivable of $0.00 Mil can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Tobacco Products company?
A good Notes Receivable depends on the Tobacco Products industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Papa Medical and its competitors. Papa Medical's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Papa Medical (PAPA), the current Notes Receivable is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.